| __timestamp | MannKind Corporation | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79383000 | 19928000 |
| Thursday, January 1, 2015 | 108402000 | 30842000 |
| Friday, January 1, 2016 | 46928000 | 46527000 |
| Sunday, January 1, 2017 | 74959000 | 34451000 |
| Monday, January 1, 2018 | 79716000 | 34409000 |
| Tuesday, January 1, 2019 | 74669000 | 34417000 |
| Wednesday, January 1, 2020 | 59040000 | 145290000 |
| Friday, January 1, 2021 | 77417000 | 298358000 |
| Saturday, January 1, 2022 | 91473000 | 488691000 |
| Sunday, January 1, 2023 | 94314000 | 468946000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. From 2014 to 2023, MannKind Corporation and Novavax, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. MannKind's SG&A expenses have remained relatively stable, averaging around $78 million annually, with a notable peak in 2015. In contrast, Novavax's spending surged dramatically, especially post-2020, reflecting a strategic pivot likely driven by its COVID-19 vaccine development. By 2022, Novavax's SG&A expenses had skyrocketed to nearly $489 million, a staggering 2,350% increase from 2014. This divergence highlights the differing strategic priorities and market responses of these two companies. As the pharmaceutical industry continues to adapt to global health challenges, such financial insights offer a window into corporate strategies and market positioning.
Eli Lilly and Company and Novavax, Inc.: SG&A Spending Patterns Compared
Merck & Co., Inc. vs MannKind Corporation: SG&A Expense Trends
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Novavax, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Catalent, Inc. and MannKind Corporation
Catalent, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Jazz Pharmaceuticals plc or MannKind Corporation: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Novavax, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
HUTCHMED (China) Limited and MannKind Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation
Operational Costs Compared: SG&A Analysis of Geron Corporation and MannKind Corporation